|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 188.55 INR | +0.53% |
|
+0.51% | -16.90% |
| 14/04 | Hikal Limited Announces Superannuation of Vimaldeep Kulshrestha as President - Crop Protection, Effective April 14, 2026 | CI |
| 12/02 | Hikal Limited, Q3 2026 Earnings Call, Feb 11, 2026 |
| Capitalization | 2.31TCr 25Cr 21Cr 19Cr 18Cr 34Cr 34Cr 226.51Cr 89Cr 1.11TCr 93Cr 91Cr 3.94TCr | P/E ratio 2026 * |
117x | P/E ratio 2027 * | 23.2x |
|---|---|---|---|---|---|
| Enterprise value | 2.31TCr 25Cr 21Cr 19Cr 18Cr 34Cr 34Cr 226.51Cr 89Cr 1.11TCr 93Cr 91Cr 3.94TCr | EV / Sales 2026 * |
1.34x | EV / Sales 2027 * | 1.19x |
| Free-Float |
30.92% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Hikal Limited
| 11/02 | Hikal : Q3FY26 Results Presentation | PU |
| 11/02 | Hikal : Results Q3FY26 | PU |
| 11/02 | Hikal : Press Release Q3FY26 | PU |
| 18/11 | Hikal : Related Party Transaction September 2025 | PU |
| 13/11 | Hikal : Results Presentation Q2FY26 | PU |
| 1 day | +0.53% | ||
| 1 week | +0.51% | ||
| Current month | +28.22% | ||
| 1 month | +20.25% | ||
| 3 months | -5.70% | ||
| 6 months | -22.79% | ||
| Current year | -16.90% |
| 1 week | 185 |  | 195 |
| 1 month | 145.95 | | 195 |
| Current year | 145.95 | | 230 |
| 1 year | 145.95 | | 449.3 |
| 3 years | 145.95 | | 464.5 |
| 5 years | 145.95 | | 742 |
| 10 years | 57 | | 742 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 01/01/1996 | |
Kuldeep Jain
DFI | Director of Finance/CFO | - | 05/11/2020 |
Pankaj Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 26/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jai Hiremath
CHM | Chairman | 78 | 16/05/2012 |
| Director/Board Member | 52 | 01/01/1996 | |
| Director/Board Member | 74 | 05/02/1992 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.53% | +0.51% | -54.12% | -35.88% | 25Cr | |
| -1.83% | -2.11% | +10.39% | +134.40% | 81TCr | |
| -1.96% | -5.81% | +44.12% | +39.01% | 54TCr | |
| +0.69% | -2.44% | +20.55% | +26.30% | 36TCr | |
| -1.37% | +0.60% | +25.20% | +13.86% | 32TCr | |
| +0.27% | -1.16% | +43.93% | +19.98% | 31TCr | |
| +0.16% | -1.59% | +28.43% | +30.11% | 28TCr | |
| -3.88% | -6.17% | +44.59% | -2.44% | 28TCr | |
| -1.51% | -1.74% | +26.01% | +41.42% | 19TCr | |
| +0.60% | -1.23% | -36.22% | -56.87% | 17TCr | |
| Average | -0.15% | -1.77% | +15.29% | +20.99% | 32.66TCr | |
| Weighted average by Cap. | -0.41% | -2.35% | +24.65% | +47.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.73TCr 18Cr 16Cr 14Cr 14Cr 25Cr 26Cr 169.08Cr 67Cr 828.31Cr 69Cr 68Cr 2.94TCr | 1.94TCr 21Cr 18Cr 16Cr 15Cr 28Cr 29Cr 190.3Cr 75Cr 932.29Cr 78Cr 76Cr 3.31TCr |
| Net income | 20Cr 21.7L 18.46L 16.93L 16.06L 29.62L 30.28L 1.99Cr 78.25L 9.74Cr 81.39L 79.71L 35Cr | 100Cr 1.06Cr 90.49L 83L 78.74L 1.45Cr 1.48Cr 9.75Cr 3.84Cr 48Cr 3.99Cr 3.91Cr 169.56Cr |
| Net Debt | - | - |
Employees
2,062
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | 188.55 ₹ | +0.53% | 13,273 |
| 21/26/21 | 187.55 ₹ | -0.66% | 37,417 |
| 20/26/20 | 188.80 ₹ | -1.74% | 23,026 |
| 17/26/17 | 192.15 ₹ | +1.91% | 24,273 |
| 16/26/16 | 188.55 ₹ | +0.51% | 10,579 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
187.55INR
Average target price
320.00INR
Spread / Average Target
+70.62%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIKAL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition